Developing treatment for spinal and bulbar muscular atrophy

This publication has 34 references indexed in Scilit:

• Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy
  Neuron, 2009
• Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy
  Human Molecular Genetics, 2009
• Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk
  Journal of Neuroscience, 2009
• Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy
  Annals of Neurology, 2009
• Mitochondrial abnormalities in spinal and bulbar muscular atrophy
  Human Molecular Genetics, 2008
• HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
  Nature, 2007
• Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity
  Human Molecular Genetics, 2007
• ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
  Nature Medicine, 2007
• 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
  Nature Medicine, 2005
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
  Nature, 1991